|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/00 | |
| A61K 48/00 | |||
| C12N 15/88 |
| (11) | Patento numeris | 2970940 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14718277.8 |
| Europos patento paraiškos padavimo data | 2014-03-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/028330 |
| Data | 2014-03-14 |
| (87) | Numeris | WO 2014/152940 |
| Data | 2014-09-25 |
| (30) | Numeris | Data | Šalis |
| 201361784766 P | 2013-03-14 | US |
| (72) |
HEARTLEIN, Michael, US
|
| (73) |
Translate Bio, Inc.,
29 Hartwell Avenue, Lexington, MA 02421,
US
|
| (54) | MRNA THERAPEUTIC COMPOSITIONS AND USE TO TREAT DISEASES AND DISORDERS |
| MRNA THERAPEUTIC COMPOSITIONS AND USE TO TREAT DISEASES AND DISORDERS |